SCHEMBL1331618

SCHEMBL1331618

CCCCC/C=C\C/C=C\CCCCCCC(C)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
PPARG P37231 5/20 0.60
F7 P08709 4/20 0.60
F3 P13726 4/20 0.60
PPARD Q03181 4/20 0.60
PPARA Q07869 4/20 0.60
KDM4E B2RXH2 4/20 0.60
FFAR1 O14842 3/20 0.60
LMNA P02545 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP19A1 P11511 2/20 0.60
FABP4 P15090 2/20 0.60
HPGD P15428 2/20 0.60
ALOX15 P16050 2/20 0.60
PTGS1 P23219 2/20 0.60
AKR1C3 P42330 2/20 0.60
NR4A2 P43354 2/20 0.60
HSD17B10 Q99714 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
DUSP3 P51452 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11869321 1.00 ALDH1A1 (0.60) ALDH1A1PPARGF7F3PPARD
SCHEMBL11861396 1.00 ALDH1A1 (0.60) ALDH1A1PPARGF7F3PPARD
SCHEMBL11861390 1.00 ALDH1A1 (0.60) ALDH1A1PPARGF7F3PPARD
SCHEMBL17629191 1.00 ALDH1A1 (0.60) ALDH1A1PPARGF7F3PPARD
SCHEMBL28502905 1.00 ALDH1A1 (0.60) ALDH1A1PPARGF7F3PPARD
SCHEMBL10481473 0.98 PPARG (0.59) ALDH1A1PPARGF7F3PPARD
SCHEMBL10481472 0.98 PPARG (0.59) ALDH1A1PPARGF7F3PPARD
SCHEMBL8659606 0.97 ALDH1A1 (0.56) ALDH1A1PPARGF7F3PPARD
SCHEMBL8659602 0.97 ALDH1A1 (0.56) ALDH1A1PPARGF7F3PPARD
SCHEMBL1370453 0.95 PPARG (0.59) ALDH1A1PPARGF7F3PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12514254-B2 Rosa canina rosehip UNIVERSITA′ DEGLI STUDI DI CAGLIARI (IT) 2026-01-06 US claimed
WO-2024128869-A1 PHARMACEUTICAL COMPOSITION FOR AMELIORATING, PREVENTING, OR TREATING FATTY LIVER DISEASE, COMPRISING METHYL LINOLEIC ACID 부산대학교 산학협력단 2024-06-20 WO claimed
US-20240041054-A1 ROSA CANINA ROSEHIP UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) 2024-02-08 US claimed
EP-4294361-A1 ROSEHIP UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) 2023-12-27 EP claimed
WO-2022136907-A1 ROSEHIP UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) 2022-06-30 WO claimed
CN-114272321-A Traditional Chinese medicine formula for regulating and controlling intestinal function of old people 华子昂 2022-04-05 CN claimed
EP-3011041-B1 BIODIESEL COMPOSITION AND RELATED PROCESS AND PRODUCTS ARGENT ENERGY UK LTD (GB) 2020-02-19 EP claimed
EP-2909261-B1 EPOXIDIZED FATTY ACID ALKYL ESTER PLASTICIZERS AND METHODS FOR MAKING EPOXIDIZED FATTY ACID ALKYL ESTER PLASTICIZERS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-03 EP claimed
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
EP-2737039-B1 FATTY ACYL AMIDO BASED SURFACTANT CONCENTRATES UNILEVER PLC (GB) 2016-03-30 EP claimed
WO-2024128869-A1 PHARMACEUTICAL COMPOSITION FOR AMELIORATING, PREVENTING, OR TREATING FATTY LIVER DISEASE, COMPRISING METHYL LINOLEIC ACID 부산대학교 산학협력단 2024-06-20 WO disclosed
EP-2183204-B1 THERMAL METHODS FOR TREATING A METATHESIS FEEDSTOCK WILMAR TRADING PTE LTD (SG) 2024-06-19 EP disclosed
CN-117603748-A Preparation method of furan-based low-viscosity lubricating oil base oil 重庆工商大学 2024-02-27 CN disclosed
CN-117298159-A Pen Luo Zijing with anti-tumor activity, leaf extract, detection method and application thereof 广州卫生职业技术学院 2023-12-29 CN disclosed
US-20230174454-A1 PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE GENOMATICA, INC. 2023-06-08 US disclosed
US-6229032-B1 MICROPORES AND SHAPE OF ZEOLITES HAVING SELECTIVITY ENABLE DIFFERENTIATION BETWEEN CIS- AND TRANS-ISOMERS OF UNSATURATED FATTY ACID COMPOUNDS OF >1; NON-ISOMERIZING; DIETETICS K. U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2001-05-08 US disclosed
WO-2001012800-A2 METHOD FOR THE PRODUCTION OF CALENDIC ACID, A FATTY ACID CONTAINING DELTA-8,10,12 CONJUGATED DOUBLE BONDS AND DIMORPHECOLIC ACID, A FATTY ACID CONTAINING A 9-HYDROXY GROUP AND DELTA-10,12 CONJUGATED DOUBLE BONDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-02-22 WO disclosed
EP-0917561-A2 ELIMINATION OF TRANS-UNSATURATED FATTY ACID COMPOUNDS BY SELECTIVE ADSORPTION WITH ZEOLITES K.U. Leuven Research & Development (BE) 1999-05-26 EP disclosed
WO-1998054275-A2 ELIMINATION OF TRANS-UNSATURATED FATTY ACID COMPOUNDS BY SELECTIVE ADSORPTION WITH ZEOLITES K. U. LEUVEN RESEARCH & DEVELOPMENT (BE) 1998-12-03 WO disclosed
EP-0010325-A1 Process and solvent for the separation of fatty acid ester mixtures with cation exchange resin THE PROCTER & GAMBLE COMPANY (US) 1980-04-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174454-A1 PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE CYP8B1, GRHPR, HCAR3 ALDH1A1 967/4885PPARG 3069/4885F7 1449/4885
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS LPO, QDPR, TYR ALDH1A1 252/4885PPARG 1140/4885F7 2086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.